시장보고서
상품코드
1181675

세계의 특수 효소 시장 : 전망과 예측(2022-2027년)

Specialty Enzymes Market - Global Outlook & Forecast 2022-2027

발행일: | 리서치사: Arizton Advisory & Intelligence | 페이지 정보: 영문 221 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 특수 효소 시장 규모는 2022-2027년에 CAGR로 7.46%의 성장이 예측됩니다.

세계의 특수 효소 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인, 경쟁 구도 등을 정리하여 전해드립니다.

목차

제1장 조사 방법

제2장 조사 목적

제3장 조사 프로세스

제4장 범위

제5장 리포트 전제조건과 주의사항

제6장 주요 인사이트

  • 서론
  • 시장 요약
    • 촉진요인
    • 기회
    • 과제
  • 부문 리뷰
    • 최종 용도
    • 유형
    • 유래
    • 지역
  • 기업과 전략

제7장 시장의 개요

제8장 서론

  • 개요
  • 밸류체인 분석
    • 원재료
    • 특수 효소 제조업체
    • 판매업체
    • 용도
  • 거시경제 요인
    • 제약 산업

제9장 시장 기회와 동향

제10장 시장 성장 촉진요인

제11장 시장 억제요인

제12장 시장 구도

  • 시장의 개요
  • 시장 규모와 예측
  • Five forces 분석

제13장 유형별

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 카르보히드라아제
  • 프로테아제
  • 리파아제
  • 폴리메라아제, 뉴클레아제
  • 기타

제14장 최종 사용별

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 제약
  • 바이오테크놀러지
  • 진단
  • 기타 최종 용도

제15장 유래별

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 미생물
  • 식물
  • 동물

제16장 지역

  • 시장 스냅숏과 성장 엔진
  • 지역적 개요

제17장 북미

  • 시장의 개요
  • 시장 규모와 예측
  • 유형
  • 최종 용도
  • 유래
  • 주요 국가
  • 미국
  • 캐나다

제18장 유럽

  • 시장의 개요
  • 시장 규모와 예측
  • 유형
  • 최종 용도
  • 유래
  • 주요 국가
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 영국
  • 러시아
  • 기타 유럽

제19장 아시아태평양

  • 시장의 개요
  • 시장 규모와 예측
  • 유형
  • 최종 용도
  • 유래
  • 주요 국가
  • 중국
  • 일본
  • 인도
  • 한국
  • 아시아태평양의 기타 국가

제20장 중동·아프리카

  • 시장의 개요
  • 시장 규모와 예측
  • 유형
  • 최종 용도
  • 유래
  • 주요 국가
  • 사우디아라비아
  • 남아프리카공화국
  • 기타 중동·아프리카

제21장 라틴아메리카

  • 시장의 개요
  • 시장 규모와 예측
  • 유형
  • 최종 용도
  • 유래
  • 주요 국가
  • 브라질
  • 멕시코
  • 기타 라틴아메리카

제22장 경쟁 구도

  • 경쟁의 개요
  • 최근의 발전

제23장 주요 기업 개요

  • BASF SE
  • DSM
  • DUPONT
  • F. HOFFMANN-LA ROCHE LTD
  • NOVOZYMES

제24장 기타 유명 벤더

  • AMANO ENZYME INC.
  • AMYRA BIOTECH AG
  • ANTOZYME BIOTECH PVT LTD
  • AUMGENE BIOSCIENCES
  • AUMENZYMES
  • BBI SOLUTIONS
  • BIOCATALYSTS
  • CODEXIS
  • CHR. HANSEN HOLDING A/S
  • DYADIC INTERNATIONAL INC.
  • IOSYNTH
  • MERCK KGAA
  • NATURE BIOSCIENCE PVT. LTD.
  • SPECIALTY ENZYMES & PROBIOTICS
  • ZYMTRONIX, INC.

제25장 리포트 요약

  • 주요 사항
  • 전략적 권장사항

제26장 정량적 요약

제27장 부록

KSA 23.01.19

The global specialty enzymes market is expected to grow at a CAGR of 7.46% during 2022-2027.

MARKET OVERVIEW

  • Factors such as the rapidly increasing global population, increasing research & development, spreading new infectious diseases, increasing biofuel usage, and growing agriculture industry led to increased demand for specialty enzymes in the global market. The major drivers of the specialty enzymes market include the increasing health consciousness and intense penetration of the pharmaceutical, diagnostics, and biotechnology industries.
  • Specialty enzymes are used in various industries for various purposes. In the pharmaceutical industry, these are used for manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments. The demand is increasing due to increasing awareness and changing government policies. With the growing specialty enzymes markets, companies must increase the supply of raw materials to produce enzymes in bulk quantities. In the pharmaceutical industry, companies have started using biobased drugs to improve product quality. Companies are adopting sustainable standards in their manufacturing processes. The specialty enzymes market has helped to reduce the by-products in the production process. Companies are getting good financial returns by using specialty enzymes in the production processes. Thus, the global demand for specialty enzymes is increasing.
  • The US contributed more than half of the overall demand in North America. Globally, the demand for specialty enzymes is very high in the US, and North America dominates the global specialty enzymes market. The US has the world's top 10 pharmaceutical companies' head offices. Thus, the demand for specialty enzymes in North America's pharmaceutical industry is increasing with the growing pharmaceutical industry.

MARKET TRENDS & DRIVERS

Increased Use in Diagnostics Sector

  • The diagnostics industry includes two categories such as pathology and radiology. Pathology is used for testing all types of illness, whereas radiology is used for testing images related to diagnoses such as x-rays, CT scans, and others. For the research & development of vaccines for various infectious diseases, enzymes are used. Enzymes are used in testing infectious diseases such as coronaviruses and influenza and are also used in nucleic acid detection. The enzymes are used in the diagnostics and analysis of biological abnormalities.
  • The diagnostics segment plays a crucial role in the healthcare sector. After the Covid-19 pandemic, the demand for proper diagnostic equipment and processes in the diagnostics sector is growing rapidly. In the testing of coronaviruses and other infectious diseases, enzymes are used. For immediate recovery from coronavirus diseases, antibiotics are used, which are produced from enzymes. Thus, the specialty enzymes market in the diagnostic sector is increasing globally.

Increasing Demand from Pharmaceutical Industry

  • The global revenue of the pharmaceutical industry is increasing due to the global demand for pharmaceutical products. The factors driving the demand for pharmaceutical products include changing clinical practices, aging-related issues, and rising chronic diseases. After the Covid-19 pandemic, the demand for pharmaceutical products used to improve quality of life and preventive approach. The global market of pharmaceutical drugs is increasing due to the lowering the regulatory barrier for new drugs in the US.
  • The health consciousness of people has increased after the Covid-19 pandemic. People prefer bio-based pharmaceutical products. Thus, the demand for bio-based substances used in manufacturing antibiotics is rising. Specialty enzymes are used in the pharmaceutical industry to increase the reaction rate and produce the desired molecules, contributing to the specialty enzymes market growth.

INDUSTRY RESTRAINTS

Technical Barriers Affecting Specialty Enzymes Market

  • Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, specialty enzymes play an essential role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of specialty enzymes. The process is time-consuming and requires more catalysts to fulfilling the need of the chemical reaction process. For the manufacturing process of these enzymes, specific conditions such as new concentration, new substrate, and other conditions are required which are not found readily in nature. These unresolved challenges make specialty enzymes unpredictive. Thus, more research & development is necessary for making enzymes in bulk amounts, creating a barrier to the specialty enzymes market growth.

SEGMENTATION INSIGHTS

INSIGHTS BY END-USE

In the pharmaceutical industry, specialty enzymes are very useful and good for treating various diseases. As there is increasing demand for pharmaceutical products, the enzyme has become essential to meet the demand for sustainable and safe industry processes. The specialty enzymes are primarily used in the pharmaceutical and biotechnology industry for research & development and diagnostics. The global specialty enzymes market in the pharmaceutical industry was valued at USD 976.56 million in 2021. The demand for specialty enzymes in North America and APAC is very high due to the increasing pharmaceutical and biotechnology industry.

In the biotechnology industry, specialty enzymes are used to increase biochemical reaction rates. Lipases are used in dietary drugs and it is used to increase the metabolism rate. Polymerases & nucleases are used in DNA amplification. In DNA amplification, the increase in the number of the gene causes an increase in proteins and RNA. Thus, it may increase the cancer cells or lower the anticancer cells. Hence, the polymerases & nucleases-based enzymes demand is growing in the global specialty enzymes market.

Segmentation by End Use

  • Pharmaceutical
  • Biotechnology
  • Diagnostics
  • Other Specialty

INSIGHTS BY TYPE

Carbohydrases have dominated the global specialty enzymes market and is expected to reach USD 1.9 billion by 2027. Carbohydrases are mainly used in the pharmaceutical industry as specialty enzymes. Most of these enzymes used in the pharmaceutical industry are produced from microorganisms, animals, and plants. Carbohydrases are further classified into glucosidase, pectinases, alpha, beta amylases, cellulases, mannanases, galacto, and pullulanase. These are the cost-effective processes in industrial applications; thus, a cheap technique is required to obstruct.

The global proteases-based specialty enzymes market surpassed USD813 million in 2021. The proteases are used in the biotechnology, pharmaceutical, and diagnostics industries-the high use of proteases in the pharmaceutical industry for prognostic and diagnostic biomarkers. Based on the catalysis mechanism, the proteases are classified into additional classes, such as glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.

Segmentation by Type

  • Carbohydrase
  • Proteases
  • Lipases
  • Polymerases & nucleases

INSIGHTS BY SOURCE

Globally, microorganisms-based enzymes contributed 77.47%, followed by animal and plant-based enzymes in 2021 in the global specialty enzymes market. The demand for specialty enzymes is very high in North America, followed by Europe and APAC. Microorganisms and plant-based enzymes are easily found in the environment. Animal-based enzymes have fewer resources, and it isn't easy to produce in bulk quantities. Thus, companies are focusing on producing enzymes from microorganisms and plants.

The global plants-based specialty enzymes market was valued at USD 297.07 million in 2021. These are used in the agriculture industry to reduce insects from crops. The few plant-based enzymes are phosphatase, esterase, glucanase, chitinase, and others. These enzymes play a crucial role in the production of nutrition. Further, plant-based enzymes are being used to manufacture drugs in the pharmaceutical industry to improve the digestive system.

Segmentation by Source

  • Microorganisms
  • Plants
  • Animal

GEOGRAPHICAL ANALYSIS

The global specialty enzymes market is diverse, with many established and potential growth markets. North America is the leading market because of rapidly developing infrastructure and readily increasing population, increasing demand for various pharmaceutical, biotechnology, and diagnostics industries. The specialty enzymes market in North America was valued at USD 1.2 billion in 2021.

Europe is the second-largest market for specialty enzymes. The growth is supported by the increasing demand for healthy pharmaceutical products, which is attributed to the rising health consciousness. Germany, France, Italy, Spain, the UK, Russia, and others led the region. In European countries, various companies are producing specialty enzymes that contribute to the global specialty enzymes market, such as BASF SE (Germany), Johnson Matthey (UK), Biocatalysts (UK), BBI Solutions (UK), and others. Furthermore, the demand is expected to grow significantly as the APAC region population has grown tremendously in recent years. China, Japan, India, and South Korea led the region. The population of APAC countries is increasing rapidly; thus, demand for pharmaceutical and diagnostics specialty enzymes is increasing. China, India, and Japan are the major pharmaceutical industry players in the APAC region.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

COMPETITIVE LANDSCAPE

The major companies in the specialty enzymes market are following the merger and acquisition strategy. This gives companies a competitive advantage that boosts their market share of the company. The key companies have undertaken various strategies to grow in the market. The growth in sustainable processes and initiatives has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable specialty enzyme products.

Some major players in the global specialty enzymes market include Roche (Switzerland), BASF SE (Germany), DuPont (US), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies like acquisitions, expansion, joint ventures, new product development, and others to increase their revenues in the industry. Other prominent companies such as Chr. Hansen Holding A/S (Denmark), Codexis (US), BBI Solutions (UK), and others have invested significant capital in R&D to develop specialty enzymes-based products that will appeal to customers. Therefore, these other prominent companies are giving tough competition to major companies.

Key Vendors

  • BASF SE
  • DSM
  • DuPont
  • F. Hoffmann-La Roche Ltd
  • Novozymes

Other Prominent Vendors

  • Amano Enzyme Inc.
  • Amayra Biotech AG
  • Antozyme Biotech Pvt Ltd
  • Aumgene Biosciences
  • Aumenzymes
  • BBI Solutions
  • Biocatalysts
  • Codexis
  • Hansen Holding A/S
  • Dyadic International Inc.
  • Iosynth
  • Merck KGaA
  • Nature Bioscience Pvt. Ltd.
  • Specialty Enzymes & Probiotics
  • Zymtronix Inc.

KEY QUESTIONS ANSWERED

  • 1. What was the global specialty enzymes market size in 2021?
  • 2. What is the growth rate of the global specialty enzymes market?
  • 3. What are the key trends in the Specialty Enzymes Market in the world?
  • 4. Which are the key companies in the global specialty enzymes market?
  • 5. Which end-use segment is estimated to lead the Global Specialty Enzymes Market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 MARKET SYNOPSIS
    • 6.2.1 DRIVERS
    • 6.2.2 OPPORTUNITY
    • 6.2.3 CHALLENGES
  • 6.3 SEGMENT REVIEW
    • 6.3.1 END-USE
    • 6.3.2 TYPE
    • 6.3.3 SOURCE
    • 6.3.4 GEOGRAPHY
  • 6.4 COMPANIES & STRATEGIES

7 MARKET AT A GLANCE

8 INTRODUCTION

  • 8.1 OVERVIEW
  • 8.2 VALUE CHAIN ANALYSIS
    • 8.2.1 RAW MATERIALS
    • 8.2.2 SPECIALTY ENZYME MANUFACTURERS
    • 8.2.3 DISTRIBUTORS
    • 8.2.4 APPLICATIONS
  • 8.3 MACROECONOMIC FACTORS
    • 8.3.1 PHARMACEUTICAL INDUSTRY

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 DEMAND FROM PHARMACEUTICAL INDUSTRY
  • 9.2 ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PROFITABILITY & PRODUCTIVITY
  • 9.3 DEMAND FROM EMERGING ECONOMIES

10 MARKET GROWTH ENABLERS

  • 10.1 DEMAND FOR BIO-SOURCED PRODUCTS
  • 10.2 INCREASED USE IN DIAGNOSTICS SECTOR
  • 10.3 INCREASED R&D & PRODUCT INNOVATION IN DEVELOPED COUNTRIES

11 MARKET RESTRAINTS

  • 11.1 LACK OF AWARENESS OF BIO-BASED PRODUCTS
  • 11.2 EXISTENCE OF VARIOUS TECHNICAL BARRIERS
  • 11.3 HIGH MANUFACTURING COST

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 BY TYPE

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 CARBOHYDRASES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 PROTEASES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 LIPASES
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 POLYMERASES & NUCLEASES
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY
  • 13.7 OTHER
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST
    • 13.7.3 MARKET BY GEOGRAPHY

14 BY END-USE

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 PHARMACEUTICAL
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 BIOTECHNOLOGY
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 DIAGNOSTICS
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY
  • 14.6 OTHER END-USE
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 MARKET BY GEOGRAPHY

15 BY SOURCE

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 MICROORGANISM
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 PLANT
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY
  • 15.5 ANIMAL
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
    • 15.5.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 TYPE
    • 17.3.1 MARKET SIZE & FORECAST
  • 17.4 END-USE
    • 17.4.1 MARKET SIZE & FORECAST
  • 17.5 SOURCE
    • 17.5.1 MARKET SIZE & FORECAST
  • 17.6 KEY COUNTRIES
  • 17.7 US
    • 17.7.1 MARKET SIZE & FORECAST
  • 17.8 CANADA
    • 17.8.1 MARKET SIZE & FORECAST

18 EUROPE

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 TYPE
    • 18.3.1 MARKET SIZE & FORECAST
  • 18.4 END-USE
    • 18.4.1 MARKET SIZE & FORECAST
  • 18.5 SOURCE
    • 18.5.1 MARKET SIZE & FORECAST
  • 18.6 KEY COUNTRIES
  • 18.7 GERMANY
    • 18.7.1 MARKET SIZE & FORECAST
  • 18.8 FRANCE
    • 18.8.1 MARKET SIZE & FORECAST
  • 18.9 ITALY
    • 18.9.1 MARKET SIZE & FORECAST
  • 18.10 SPAIN
    • 18.10.1 MARKET SIZE & FORECAST
  • 18.11 UK
    • 18.11.1 MARKET SIZE & FORECAST
  • 18.12 RUSSIA
    • 18.12.1 MARKET SIZE & FORECAST
  • 18.13 REST OF EUROPE
    • 18.13.1 MARKET SIZE & FORECAST

19 APAC

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 TYPE
    • 19.3.1 MARKET SIZE & FORECAST
  • 19.4 END-USE
    • 19.4.1 MARKET SIZE & FORECAST
  • 19.5 SOURCE
    • 19.5.1 MARKET SIZE & FORECAST
  • 19.6 KEY COUNTRIES
  • 19.7 CHINA
    • 19.7.1 MARKET SIZE & FORECAST
  • 19.8 JAPAN
    • 19.8.1 MARKET SIZE & FORECAST
  • 19.9 INDIA
    • 19.9.1 MARKET SIZE & FORECAST
  • 19.10 SOUTH KOREA
    • 19.10.1 MARKET SIZE & FORECAST
  • 19.11 REST OF APAC
    • 19.11.1 MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 TYPE
    • 20.3.1 MARKET SIZE & FORECAST
  • 20.4 END-USE
    • 20.4.1 MARKET SIZE & FORECAST
  • 20.5 SOURCE
    • 20.5.1 MARKET SIZE & FORECAST
  • 20.6 KEY COUNTRIES
  • 20.7 SAUDI ARABIA
    • 20.7.1 MARKET SIZE & FORECAST
  • 20.8 SOUTH AFRICA
    • 20.8.1 MARKET SIZE & FORECAST
  • 20.9 REST OF MIDDLE EAST & AFRICA
    • 20.9.1 MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 TYPE
    • 21.3.1 MARKET SIZE & FORECAST
  • 21.4 END-USE
    • 21.4.1 MARKET SIZE & FORECAST
  • 21.5 SOURCE
    • 21.5.1 MARKET SIZE & FORECAST
  • 21.6 KEY COUNTRIES
  • 21.7 BRAZIL
    • 21.7.1 MARKET SIZE & FORECAST
  • 21.8 MEXICO
    • 21.8.1 MARKET SIZE & FORECAST
  • 21.9 REST OF LATIN AMERICA
    • 21.9.1 MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

  • 22.1 COMPETITION OVERVIEW
  • 22.2 RECENT DEVELOPMENTS

23 KEY COMPANY PROFILES

  • 23.1 BASF SE
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 FINANCIAL OVERVIEW
    • 23.1.3 PRODUCT OFFERINGS
    • 23.1.4 KEY STRATEGIES
    • 23.1.5 KEY STRENGTHS
    • 23.1.6 KEY OPPORTUNITIES
  • 23.2 DSM
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 FINANCIAL OVERVIEW
    • 23.2.3 PRODUCT OFFERINGS
    • 23.2.4 KEY STRATEGIES
    • 23.2.5 KEY STRENGTHS
    • 23.2.6 KEY OPPORTUNITIES
  • 23.3 DUPONT
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 FINANCIAL OVERVIEW
    • 23.3.3 PRODUCT OFFERINGS
    • 23.3.4 KEY STRATEGIES
    • 23.3.5 KEY STRENGTHS
    • 23.3.6 KEY OPPORTUNITIES
  • 23.4 F. HOFFMANN-LA ROCHE LTD
    • 23.4.1 BUSINESS OVERVIEW
    • 23.4.2 FINANCIAL OVERVIEW
    • 23.4.3 PRODUCT OFFERINGS
    • 23.4.4 KEY STRATEGIES
    • 23.4.5 KEY STRENGTHS
    • 23.4.6 KEY OPPORTUNITIES
  • 23.5 NOVOZYMES
    • 23.5.1 BUSINESS OVERVIEW
    • 23.5.2 FINANCIAL OVERVIEW
    • 23.5.3 PRODUCT OFFERINGS
    • 23.5.4 KEY STRATEGIES
    • 23.5.5 KEY STRENGTHS
    • 23.5.6 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

  • 24.1 AMANO ENZYME INC.
    • 24.1.1 COMPANY OVERVIEW
    • 24.1.2 BUSINESS OVERVIEW
    • 24.1.3 PRODUCT OFFERINGS
  • 24.2 AMYRA BIOTECH AG
    • 24.2.1 COMPANY OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
  • 24.3 ANTOZYME BIOTECH PVT LTD
    • 24.3.1 COMPANY OVERVIEW
    • 24.3.2 BUSINESS OVERVIEW
    • 24.3.3 PRODUCT OFFERINGS
  • 24.4 AUMGENE BIOSCIENCES
    • 24.4.1 COMPANY OVERVIEW
    • 24.4.2 BUSINESS OVERVIEW
    • 24.4.3 PRODUCT OFFERINGS
  • 24.5 AUMENZYMES
    • 24.5.1 COMPANY OVERVIEW
    • 24.5.2 PRODUCT OFFERINGS
  • 24.6 BBI SOLUTIONS
    • 24.6.1 COMPANY OVERVIEW
    • 24.6.2 BUSINESS OVERVIEW
    • 24.6.3 PRODUCT OFFERINGS
  • 24.7 BIOCATALYSTS
    • 24.7.1 COMPANY OVERVIEW
    • 24.7.2 BUSINESS OVERVIEW
    • 24.7.3 PRODUCT OFFERINGS
  • 24.8 CODEXIS
    • 24.8.1 COMPANY OVERVIEW
    • 24.8.2 BUSINESS OVERVIEW
    • 24.8.3 PRODUCT OFFERINGS
  • 24.9 CHR. HANSEN HOLDING A/S
    • 24.9.1 COMPANY OVERVIEW
    • 24.9.2 BUSINESS OVERVIEW
    • 24.9.3 PRODUCT OFFERINGS
  • 24.10 DYADIC INTERNATIONAL INC.
    • 24.10.1 COMPANY OVERVIEW
    • 24.10.2 BUSINESS OVERVIEW
    • 24.10.3 PRODUCT OFFERINGS
  • 24.11 IOSYNTH
    • 24.11.1 COMPANY OVERVIEW
    • 24.11.2 BUSINESS OVERVIEW
    • 24.11.3 PRODUCT OFFERINGS
  • 24.12 MERCK KGAA
    • 24.12.1 COMPANY OVERVIEW
    • 24.12.2 BUSINESS OVERVIEW
    • 24.12.3 PRODUCT OFFERINGS
  • 24.13 NATURE BIOSCIENCE PVT. LTD.
    • 24.13.1 COMPANY OVERVIEW
    • 24.13.2 BUSINESS OVERVIEW
    • 24.13.3 PRODUCT OFFERINGS
  • 24.14 SPECIALTY ENZYMES & PROBIOTICS
    • 24.14.1 COMPANY OVERVIEW
    • 24.14.2 BUSINESS OVERVIEW
    • 24.14.3 PRODUCT OFFERINGS
  • 24.15 ZYMTRONIX, INC.
    • 24.15.1 COMPANY OVERVIEW
    • 24.15.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

  • 25.1 KEY TAKEAWAYS
  • 25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

  • 26.1 TYPE
    • 26.1.1 CARBOHYDRASES
    • 26.1.2 PROTEASES
    • 26.1.3 LIPASES
    • 26.1.4 POLYMERASES & NUCLEASES
    • 26.1.5 OTHER
  • 26.2 END-USE
    • 26.2.1 PHARMACEUTICAL
    • 26.2.2 BIOTECHNOLOGY
    • 26.2.3 DIAGNOSTICS
    • 26.2.4 OTHER END-USE
  • 26.3 SOURCE
    • 26.3.1 MICROORGANISM
    • 26.3.2 PLANT
    • 26.3.3 ANIMAL
  • 26.4 GEOGRAPHY
  • 26.5 NORTH AMERICA
    • 26.5.1 TYPE
    • 26.5.2 END-USE
    • 26.5.3 SOURCE
  • 26.6 EUROPE
    • 26.6.1 TYPE
    • 26.6.2 END-USE
    • 26.6.3 SOURCE
  • 26.7 APAC
    • 26.7.1 TYPE
    • 26.7.2 END-USE
    • 26.7.3 SOURCE
  • 26.8 MIDDLE EAST & AFRICA
    • 26.8.1 TYPE
    • 26.8.2 END-USE
    • 26.8.3 SOURCE
  • 26.9 LATIN AMERICA
    • 26.9.1 TYPE
    • 26.9.2 END-USE
    • 26.9.3 SOURCE

27 APPENDIX

  • 27.1 ABBREVIATIONS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제